Pharma manager bets on post-vaccine hike in routine health appointments

While active health care investor Fondita banks on medical needs in the post-Covid-19 world, the first portfolio review after the pandemic's onset will be carried out in December at Seligson's passively managed pharmaceutical fund. "We are trying to interpret what will happen in the markets after there is a vaccination," Fondita's CEO says.

Photo: Pexels

Log in to read our articles

Welcome to AMWatch. A part of our content is exclusive and reserved for our users.

Try AMWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles

amwatch trial

Latest news


See all

See all

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch